CD47 and acute myeloid leukemia: In addition, alternatively spliced CD47 isoforms were upregulated in therapy-resistant pediatric acute myeloid leukemia stem cells, and a selective splicing modulator rebecsinib reversed the splicing deregulation and prevented expansion of the pediatric acute myeloid leukemia stem cells (60).